MNKD — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.04

Margin Of Safety %

-25

Put/Call OI Ratio

0.29

EPS Next Q Diff

0.07

EPS Last/This Y

0.07

EPS This/Next Y

0.11

Price

3.38

Target Price

7.47

Analyst Recom

1.25

Performance Q

-39.32

Upside

-182.8%

Beta

1.06

Ticker: MNKD

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	MNKD	2.71	0.39	0.10	79645
2026-04-24	MNKD	2.7	0.38	0.05	79615
2026-04-27	MNKD	2.63	0.38	0.15	78494
2026-04-28	MNKD	2.79	0.38	0.03	80593
2026-04-29	MNKD	2.76	0.37	0.09	81987
2026-04-30	MNKD	2.82	0.37	0.02	82295
2026-05-01	MNKD	2.84	0.37	0.03	81819
2026-05-04	MNKD	2.81	0.34	0.06	80096
2026-05-05	MNKD	2.86	0.33	0.08	82029
2026-05-06	MNKD	3.6	0.33	0.14	82508
2026-05-07	MNKD	3.56	0.34	0.05	84844
2026-05-08	MNKD	3.51	0.33	0.42	86176
2026-05-11	MNKD	3.37	0.34	0.01	85602
2026-05-12	MNKD	3.29	0.31	0.09	91307
2026-05-13	MNKD	3.22	0.31	0.08	92181
2026-05-14	MNKD	3.21	0.30	0.07	94702
2026-05-15	MNKD	3.1	0.29	0.03	97258
2026-05-18	MNKD	2.98	0.29	0.10	83916
2026-05-19	MNKD	2.95	0.29	0.15	86270
2026-05-20	MNKD	3.24	0.29	0.09	88301
2026-05-21	MNKD	3.31	0.28	0.29	90902
2026-05-22	MNKD	3.39	0.29	0.14	93538
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	MNKD	2.71	-31.2	-	0.10
2026-04-24	MNKD	2.71	-58.3	-	0.10
2026-04-27	MNKD	2.64	-58.3	-	0.10
2026-04-28	MNKD	2.80	-58.3	-	0.09
2026-04-30	MNKD	2.82	-58.3	-	0.09
2026-05-01	MNKD	2.83	-58.3	-	0.09
2026-05-04	MNKD	2.81	-83.3	-	0.09
2026-05-05	MNKD	2.86	-83.3	-	0.09
2026-05-06	MNKD	3.57	-83.3	-	0.09
2026-05-07	MNKD	3.55	-83.3	-	0.09
2026-05-08	MNKD	3.51	-83.3	-	0.09
2026-05-11	MNKD	3.37	-83.3	-	0.09
2026-05-12	MNKD	3.29	-73.3	-	0.09
2026-05-13	MNKD	3.21	-73.3	-	0.09
2026-05-14	MNKD	3.21	-73.3	-	0.09
2026-05-15	MNKD	3.10	-73.3	-	0.09
2026-05-18	MNKD	2.98	-75.0	-	0.09
2026-05-19	MNKD	2.95	-75.0	-	0.09
2026-05-20	MNKD	3.24	-75.0	-	0.09
2026-05-21	MNKD	3.31	-75.0	-	0.09
2026-05-22	MNKD	3.38	-75.0	-	0.09
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	MNKD	-2.48	3.00	9.98
2026-04-24	MNKD	-2.48	3.00	9.96
2026-04-27	MNKD	-2.48	3.00	9.99
2026-04-28	MNKD	-2.51	3.00	9.99
2026-04-29	MNKD	-2.51	3.00	9.99
2026-04-30	MNKD	-2.51	3.00	9.99
2026-05-01	MNKD	-2.51	3.00	9.99
2026-05-04	MNKD	-2.51	2.85	9.99
2026-05-05	MNKD	-2.51	2.85	9.99
2026-05-06	MNKD	-2.51	2.85	9.99
2026-05-07	MNKD	-2.51	2.85	9.99
2026-05-08	MNKD	-2.51	2.85	9.99
2026-05-11	MNKD	-2.50	3.66	9.99
2026-05-12	MNKD	-2.50	3.66	10.04
2026-05-13	MNKD	-2.50	3.66	10.04
2026-05-14	MNKD	-2.65	3.66	10.04
2026-05-15	MNKD	-2.51	3.66	10.04
2026-05-18	MNKD	-2.51	3.83	10.04
2026-05-19	MNKD	-2.50	3.83	10.04
2026-05-20	MNKD	-2.50	3.83	10.04
2026-05-21	MNKD	-2.50	3.83	10.04
2026-05-22	MNKD	-2.50	3.83	10.04
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.05

Avg. EPS Est. Current Quarter

0.01

Avg. EPS Est. Next Quarter

0.02

Insider Transactions

-2.5

Institutional Transactions

3.83

Beta

1.06

Average Sales Estimate Current Quarter

108

Average Sales Estimate Next Quarter

119

Fair Value

2.55

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

55.6

Max Drawdown 5-Year %

-69.4

Target Price

7.47

P/E

Forward P/E

24.14

PEG

0.25

P/S

2.89

P/B

P/Free Cash Flow

79.9

EPS

-0.08

Average EPS Est. Cur. Y

0.09

EPS Next Y. (Est.)

0.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.63

Relative Volume

0.68

Return on Equity vs Sector %

13.3

Return on Equity vs Industry %

28.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

◆ MNKD Healthcare

$3.38

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

14/20

Pullback

8/25

Volume

9/15

Valuation

15/20

TP/AR

2/10

Options

8/10

RSI

61.4

Range 1M

45%

Sup Dist

5.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

13/30

Estimates

3/20

Inst/Vol

4/15

Options

8/10

EPS Yr

-200%

EPS NY

800%

52W%

26.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +65.2% upside

Quality

8/30

Valuation

19/30

Growth

8/25

Stability

6/10

LT Trend

2/5

Upside

+65.2%

Quality

MoS

-25%

MannKind Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 591

MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. Its products also include Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; FUROSCIX, a furosemide injection to treat fluid buildup in patients with chronic heart failure or chronic kidney disease. The company's pipeline of treatments for orphan lung diseases include MNKD-201, a dry-powder formulation of nintedanib for the treatment of idiopathic pulmonary fibrosis and MNKD-701. It has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.

MNKD

Latest News

—

Caricamento notizie per MNKD…

stock quote shares MNKD – MannKind Corporation Stock Price stock today

news today MNKD – MannKind Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch MNKD – MannKind Corporation yahoo finance google finance

stock history MNKD – MannKind Corporation invest stock market

stock prices MNKD premarket after hours

ticker MNKD fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MNKD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y